TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14728 · May 20

#typescript#android#appwrite#backend#backend_as_a_service#docker#firebase#flutter#hacktoberfest#hosting#ios#javascript#nextjs#react#react_native#reactnative#self_hosted#selfhosted#serverless#swift#web Appwrite is a backend platform that helps you build web, mobile, and Flutter apps quickly and easily. It handles complex tasks like user authentication, database management, file storage, and more, so you don’t have to build these from scratch. Appwrite is open source, secure, and works with many programming languages and frameworks. You can use it in the cloud or host it yourself using Docker. The main benefit is that it saves you time and effort, letting you focus on creating great features for your app instead of worrying about backend setup and maintenance[3][5][1]. https://github.com/appwrite/appwrite

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment